Aneuploid CD31+ CTECs and CD31– CTCs compose a pair of cellular circulating tumor biomarkers that may have an active cross-talk and interplay in circulation, thus promoting lymphogenous and hematogenous cancer metastasis as well as disease progression. This evidence concerns the gene PECAM1 and cancer.